Decipher Labs Ltd deals in trading and manufacturing of Pharmaceutical drugs and provides services and key solutions in Information Technology.Services Offered: a) Pharmaceuticals: Manufacturing & Marketing of Branded Formulations and Custom Manufacturing for companies. Company also caters to various formulators, manufacturers and Research and Development agencies for their Bulk needs...
Newspaper Advertisement for the Annual General Meeting to be held for the FY_2025-26.
Decipher Labs Limited has announced a board meeting where they approved the appointment of M/s. Ramanatham & Rao as Statutory Auditors for five years, subject to shareholder approval. They also appointed Mr. Sushant Mohan Lal as Internal Auditor for FY 2026-27. The board noted the resignation of Mrs. Lakshmi Vijaya...
Decipher Labs Limited has confirmed the successful completion of its share dematerialization process for the quarter ended June 30. The company reported that all necessary details regarding securities converted from physical to electronic form have been furnished to the stock exchanges. This ensures that physical share certificates are properly cancelled...
Decipher Labs' Annual Secretarial Compliance Report highlights a promoter's delayed declaration, which was subsequently rectified. More significantly, the report details a previous SEBI order against the company and its directors for violating trading regulations. The company itself was initially restricted from dealing in securities for a year. However, the directors...
Decipher Labs Limited has informed stock exchanges about its compliance regarding dematerialized shares. The company’s Registrar and Share Transfer Agent (RTA) confirmed that no securities were received for dematerialization or rematerialization during the recent period. This routine update assures shareholders of the company's adherence to processes for managing electronic shares,...
